News section
home news forum careers events suppliers solutions markets resources directories advertise contacts search site plan
 
.
Origin Agritech Ltd reports first quarter fiscal 2008 results

.

Beijing, China
March 25, 2008

• Revenues of RMB 26.36 million increased 37% from RMB 19.24 million
• Net Loss of RMB 15.37 million decreased from RMB 30.67 million
• Reiterates Revenue and Net Income Guidance for FY2008

Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”), a technology-focused supplier of crop seeds in China; today announced unaudited financial results for the first quarter ended December 31, 2007. Origin prepares its financial statements in accordance with generally accepted accounting principles (GAAP) of the United States.

RECENT COMPANY HIGHLIGHTS INCLUDE:

  • Introduction of the world’s first genetically modified phytase corn, expected to be the first approved genetically modified corn product in China.
  • Provincial approval of 6 hybrid corn seeds throughout China, helping to accumulate local germplasm to facilitate GMO products.
  • Nationwide approval of 2 hybrid corn seeds with ability to be sold across China, bringing corn seed product count to 55 total seeds.
  • Provincial approval of 6 hybrid rice seeds throughout China, bringing the total rice seed product count to 67 total seeds.
  • Completed one of the largest hybrid seed production facility in SW China (Chengdu), including a hybrid rice and corn seed conditioning plant with a capacity of 10,000 kilograms per hour, a seed testing laboratory and 4,000 square meters of administrative offices.

FINANCIAL RESULTS OVERVIEW

During the first quarter of fiscal 2008, the Company generated revenues of RMB 26.36 million (US$3.61 million), an increase of 37.03% from RMB 19.24 million (US$2.47 million) generated in the three months ended December 31, 2006. The revenues were mainly from the sales of canola seeds, which increased from RMB 18.19 million (US$2.33 million) for the three months ended December 31, 2006 to RMB 24.06 million (US$3.30 million) for the three months ended December 31, 2007.

Gross profit for the three-months ended December 31, 2007 was RMB3.34 million (US$457,284) compared to RMB 8.17 (US$1.05 million) in the same period of the prior year. Scrap sales for the quarter amounted to about RMB 2.74 million (US$375,406), mainly from the liquidation of seed products from Origin’s subsidiary, Jilin Changrong. These scrap sales amounted to about 10.4% of our total revenue and materially impacted our gross margin by 35.7%. Excluding these scrap sales; gross margins for the quarter were 48.3%, a 5.9% increase from the gross margin of 42.5%for the three months ended December 31, 2006.

Total operating expenses for the three-months ended December 31, 2007 were RMB47.01 million (US$6.44 million) compared with RMB 36.90 million (US$4.73 million) reported for the same period in 2006.

  • Selling and marketing expenses were RMB14.01 million (US$1.92 million) for the first quarter of 2007, representing an increase of 17.4% from RMB 11.93 million (US$1.53 million) for the same period of the last year. This increase was mainly due to the inclusion of Changrong’s selling and marketing expenses.
  • General and administrative expenses of RMB23.38 million (US$3.21 million) for the first quarter ended December 31, 2007, increased 12.5% from RMB20.79 million (US$2.66 million) for the three months ended December 31, 2006.
  • The major increase in operating expenses was caused by the increase in research and development expenses, which increased to RMB9.62 million (US$1.32 million) for the three-months ended December 31, 2007 from RMB4.19 million (US$536,281) for the same quarter last year, with an increase of 129.9%. 

Operating loss for the first quarter of 2007 amounted to RMB43.67 million (US$5.99 million) compared with an operating loss of RMB28.73 million (US$3.68 million) for the same period in 2006. Exclusive of the operating loss of Jilin Changrong of RM 16.19 million (US$2.22 million), the loss from operations was RMB27.48 million (US$3.77million).
Net loss for the first quarter of 2007 was RMB15.37 million (US$2.11 million), or RMB 0.67 (US$0.09) per diluted share, as compared to a net loss of RMB30.67 million (US$3.93 million), or RMB 1.31 (US$0.17) per diluted share in the same period one year ago. Exclusive of the net loss of Jilin Changrong of RMB 16.1 million (US$2.21 million), the net gain was RMB 0.72 million (US$98,657). This increase was in part due to the RMB18.99 million (US$2.6 million) in the changes in the fair value of the embedded derivatives.

BALANCE SHEET

Origin's balance sheet at December 31, 2007 included cash and cash equivalents of RMB118.53 million (US$16.25 million), investments in US Government Agency bonds amounting to RMB 131.27 million (US$18 million), working capital of RMB241.40 million (US$33.1million), and shareholders' equity of RMB285.95 million (US$39.2 million).

Deferred revenue was RMB112.05 million (US$ 15.36 million) for the three-months ended December 31, 2007 as compared to RMB 163.14 million (US$20.9 million) for the same period last year.

Advances from customers increased on a sequential basis by RMB97.53 million (US$13.37 million) for the three-months ended December 31, 2007. On a year-over-year basis, advances from customers increased by RMB76.10 million (US$10.43 million) for the three-months ended December 31, 2007.

COMPANY UPDATE

We recently updated our GMO product pipeline timelines. The glyphosate-resistance and Bt traits in our pipeline are the same traits that have historically dominated the seed industry globally.

Additionally, these particular herbicide resistance and pest resistant genes have grown at over a 50% compounded annual growth rate since being introduced in the United States. The rapid and pervasive adoption shows the high value added to farmers. We retain exclusive rights to these traits in China, have the ability to stack them, and expect to be the first company to commercialize these products in China.

The fact that GMO approval process is restricted solely for Chinese domestic companies places Origin Agritech in a strategic position that is second to none. Healthy downstream industry economics continue to surround the agriculture industry as a whole. China’s cropland estimates by the Ministry of Agriculture are consistent with overall market size growth.

Liang Yuan, President and Co-CEO of Origin concluded, “While we continue to expand our hybrid seed portfolio, we believe that biotechnology will play an increasingly important role in China. We are heavily engaged in developing GM hybrids because we believe China will eventually approve GM seeds for commercial cultivation. We are the only Chinese crop seed company with an in-house biotech center and a 34% owner of Biocentury Transgene (China) Co., Ltd. Our relationships with numerous academic institutions and state run research programs also give us to opportunity to participate in various government-sponsored research, especially for genetically modified crops. We are pleased by our success in this area thus far. We have exclusive rights to five genetic traits which are in various stages of developments. We are confident that once the GM marketplace opens in China, we will be one of the strongest domestic players to compete in the marketplace.”

FISCAL 2008 GUIDANCE

Based on its current outlook, and existing and anticipated business conditions, Origin reiterates the revenue guidance for FY 2008 in the range of US$75 million to US$80 million and net income range of US$0.5 million to US$2 million, for the fiscal year ending September 30, 2008. This net income figure is inclusive of roughly US$2.7 million dollars in expected non-cash interest expense from our convertible debt offering. Exclusive of this non-cash expense, we expect a net income range of US$3.0 to US$4.5 million.

Founded in 1997 and headquartered in Beijing, Origin Agritech Limited (NASDAQ: SEED) is one of China’s leading, vertically-integrated agricultural technology company specializing in agri-biotech research, development and production to supply the growing populations of China. Origin develops, grows, processes, and markets crop seeds to farmers throughout China and parts of Southeast Asia via a network of approximately 3,800 first-level distributors and 6,500 second-level distributors. The hybrid seed industry is estimated at US$2 billion and that is expected to double by 2010. The Company currently operates facilities in 30 of China’s 32 provinces as well as Beijing. Since Origin launched its first entirely internally developed seed in 2003, the Company has developed and commercialized an internally developed proprietary seed portfolio of twelve corn hybrids, twelve rice hybrids and two canola hybrids as of 2007.

 

 

 

 

The news item on this page is copyright by the organization where it originated - Fair use notice

Other news from this source


Copyright © SeedQuest - All rights reserved